Glory Health Industry (SEHK:2329) - Aandelenkoers, Nieuws & Analyse

2329 Overzicht aandelen

Glory Health Industry Limited, een beleggingsholding, ontwikkelt en exploiteert vastgoed in de Volksrepubliek China. Meer informatie

2329 fundamentele analyse
Sneeuwvlok Score
Waardering	2/6
Toekomstige groei	0/6
Prestaties in het verleden	0/6
Financiële gezondheid	2/6
Dividenden	0/6

Risicoanalyse

De schulden worden niet goed gedekt door de operationele kasstroom

De winst is de afgelopen 5 jaar met 65.2% per jaar gedaald

Volatiele aandelenkoers in de afgelopen 3 maanden

Heeft geen betekenisvolle marktkapitalisatie ( HK$436M )

Glory Health Industry Limited Concurrenten

Japan Kyosei Group

SEHK:627

HK$738.8m

Cosmopolitan International Holdings

SEHK:120

HK$308.5m

JY Grandmark Holdings

SEHK:2231

HK$526.8m

DIT Group

SEHK:726

HK$403.1m

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Glory Health Industry
Historische aandelenkoersen
Huidige aandelenkoers	HK$0.098
52 Week Hoogtepunt	HK$0.25
52 Week Laag	HK$0.021
Bèta	-0.018
11 maand verandering	-21.60%
3 maanden verandering	-16.95%
1 Jaar Verandering	164.86%
33 jaar verandering	-72.78%
5 jaar verandering	-93.76%
Verandering sinds IPO	-96.08%

Recent nieuws en updates

We Discuss Why Glory Health Industry Limited's (HKG:2329) CEO Compensation May Be Closely Reviewed

Jun 21

Recent updates

We Discuss Why Glory Health Industry Limited's (HKG:2329) CEO Compensation May Be Closely Reviewed

Jun 21

We Think Shareholders May Want To Consider A Review Of Guorui Properties Limited's (HKG:2329) CEO Compensation Package

Jun 23

Guorui Properties (HKG:2329) Has A Somewhat Strained Balance Sheet

May 13

Guorui Properties'(HKG:2329) Share Price Is Down 73% Over The Past Five Years.

Jan 31

Should You Use Guorui Properties's (HKG:2329) Statutory Earnings To Analyse It?

Jan 10

What Kind Of Shareholders Hold The Majority In Guorui Properties Limited's (HKG:2329) Shares?

Dec 20

Guorui Properties (HKG:2329) Has A Somewhat Strained Balance Sheet

Dec 03

Rendement voor aandeelhouders

	2329	HK Real Estate	HK Markt
7D	-28.5%	1.9%	1.4%
1Y	164.9%	-6.5%	14.9%

Rendement versus industrie: 2329 overtrof de Hong Kong Real Estate industrie, die het afgelopen jaar een rendement -6.5 % opleverde.

Rendement versus markt: 2329 overtrof de Hong Kong markt, die het afgelopen jaar een rendement opleverde van 14.9 %.

Prijsvolatiliteit

Is 2329's price volatile compared to industry and market?
2329 volatility
2329 Average Weekly Movement	14.4%
Real Estate Industry Average Movement	9.9%
Market Average Movement	8.9%
10% most volatile stocks in HK Market	19.0%
10% least volatile stocks in HK Market	4.2%

Stabiele aandelenkoers: De aandelenkoers van 2329 is de afgelopen 3 maanden volatiel geweest.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit van 2329 is het afgelopen jaar gedaald van 27% naar 14%, maar is nog steeds hoger dan 75% van de Hong Kong -aandelen.

Over het bedrijf

Opgericht	Werknemers	CEO	Website
1994	552	Zhangsun Zhang	www.glorypty.com

Glory Health Industry Limited, een beleggingsholding, ontwikkelt en exploiteert vastgoed in de Volksrepubliek China. Het bedrijf is actief in vier segmenten: Vastgoedontwikkeling, Bouw van primaire grond en ontwikkelingsdiensten, Vastgoedbeleggingen en Vastgoedbeheer en aanverwante diensten. Het segment Property Development ontwikkelt en verkoopt commercieel en residentieel vastgoed.

Glory Health Industry Limited Samenvatting

Hoe verhouden de winst en inkomsten van Glory Health Industry zich tot de beurswaarde?
2329 fundamentele statistieken
Marktkapitalisatie	HK$435.55m
Inkomsten(TTM)	-HK$380.04m
Inkomsten(TTM)	HK$2.18b

0.2x

P/S-verhouding

-1.1x

Koers/Winstverhouding

Is 2329 overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
2329 resultatenrekening (TTM)
Inkomsten	CN¥2.04b
Kosten van inkomsten	CN¥1.84b
Brutowinst	CN¥201.85m
Overige uitgaven	CN¥557.60m
Inkomsten	-CN¥355.76m

Laatst gerapporteerde inkomsten

Jun 30, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)	-0.08
Brutomarge	9.91%
Nettowinstmarge	-17.47%
Schuld/Eigen Vermogen Verhouding	161.3%

Hoe presteerde 2329 op de lange termijn?

Bekijk historische prestaties en vergelijking

2329 Overzicht aandelen

Risicoanalyse

Glory Health Industry Limited Concurrenten

SEHK:627

HK$738.8m

SEHK:120

HK$308.5m

SEHK:2231

HK$526.8m

SEHK:726

HK$403.1m

Prijsgeschiedenis en prestaties

Recent nieuws en updates

Glory Health Industry Limited Announces Change of Company Secretary

First half 2024 earnings released: CN¥0.013 loss per share (vs CN¥0.06 loss in 1H 2023)

Glory Health Industry Limited to Report First Half, 2024 Results on Aug 30, 2024

We Discuss Why Glory Health Industry Limited's (HKG:2329) CEO Compensation May Be Closely Reviewed

Glory Health Industry Limited, Annual General Meeting, Jun 28, 2024

Full year 2023 earnings released: CN¥0.13 loss per share (vs CN¥0.20 loss in FY 2022)

Recent updates

Glory Health Industry Limited Announces Change of Company Secretary

First half 2024 earnings released: CN¥0.013 loss per share (vs CN¥0.06 loss in 1H 2023)

Glory Health Industry Limited to Report First Half, 2024 Results on Aug 30, 2024

We Discuss Why Glory Health Industry Limited's (HKG:2329) CEO Compensation May Be Closely Reviewed

Glory Health Industry Limited, Annual General Meeting, Jun 28, 2024

Full year 2023 earnings released: CN¥0.13 loss per share (vs CN¥0.20 loss in FY 2022)

Glory Health Industry Limited to Report Fiscal Year 2023 Results on Mar 28, 2024

Glory Health Industry Limited Appoints Lam Yuen Ling Eva as Company Secretary

Glory Health Industry Limited Announces the Resignation of Liu Chengjiang as Independent Non-Executive Director, Chairman of the Internal Control Committee and Member of the Audit Committee

Glory Health Industry (HKG:2329) Has Debt But No Earnings; Should You Worry?

First half 2023 earnings released: CN¥0.06 loss per share (vs CN¥0.15 loss in 1H 2022)

Glory Health Industry Limited Announces Resignation of Lai Siming as an Independent Non-Executive Director

Glory Health Industry Limited to Report First Half, 2023 Results on Aug 31, 2023

Now 32% undervalued after recent price drop

Glory Health Industry Limited Announces Resignation of Kwong Yin Ping Yvonne as Joint Company Secretary and Authorised Representative, Effective July 1, 2023

Glory Health Industry Limited Announces Retirement of Luo Zhenbang as Independent Non-Executive Director

Glory Health Industry Limited Announces Resignation of Zheng Jin as Joint Company Secretary and an Authorised Representative

Health Check: How Prudently Does Glory Health Industry (HKG:2329) Use Debt?

Glory Health Industry Limited, Annual General Meeting, Jun 30, 2023

Now 21% undervalued after recent price drop

Glory Health Industry Limited Appoints Liu Chengjiang as Independent Non-Executive Director, Chairman of Internal Control Committee and Member of Audit Committee

Now 21% undervalued after recent price drop

A Look At The Fair Value Of Glory Health Industry Limited (HKG:2329)

Full year 2022 earnings released: CN¥0.20 loss per share (vs CN¥0.051 profit in FY 2021)

Glory Health Industry Limited Announces Resignation of Ms. Chen Jingru as Independent Non-Executive Director, Chairman of the Internal Control Committee of the Company and Member of the Audit Committee

Less than half of directors are independent

Glory Health Industry (HKG:2329) Has Debt But No Earnings; Should You Worry?

First half 2022 earnings released: CN¥0.15 loss per share (vs CN¥0.06 profit in 1H 2021)

Glory Health Industry Limited Provides Earnings Guidance for Six Months Ended June 30, 2022

Glory Health Industry Limited to Report First Half, 2022 Results on Aug 31, 2022

Less than half of directors are independent

We Think Guorui Properties (HKG:2329) Is Taking Some Risk With Its Debt

Full year 2021 earnings released: EPS: CN¥0.051 (vs CN¥0.022 in FY 2020)

Guorui Properties Limited to Report Fiscal Year 2021 Results on Mar 31, 2022

Less than half of directors are independent

First half 2021 earnings released: EPS CN¥0.06 (vs CN¥0.016 in 1H 2020)

Here's Why Guorui Properties (HKG:2329) Is Weighed Down By Its Debt Load

We Think Shareholders May Want To Consider A Review Of Guorui Properties Limited's (HKG:2329) CEO Compensation Package

Guorui Properties (HKG:2329) Has A Somewhat Strained Balance Sheet

Full year 2020 earnings released: EPS CN¥0.022 (vs CN¥0.19 in FY 2019)

Chairman & President recently bought HK$1.6m worth of stock

Full year 2020 earnings released: EPS CN¥0.022 (vs CN¥0.19 in FY 2019)

Guorui Properties Limited to Report Fiscal Year 2020 Results on Mar 31, 2021

New 90-day low: HK$0.73

Guorui Properties'(HKG:2329) Share Price Is Down 73% Over The Past Five Years.

Should You Use Guorui Properties's (HKG:2329) Statutory Earnings To Analyse It?

New 90-day low: HK$0.74

What Kind Of Shareholders Hold The Majority In Guorui Properties Limited's (HKG:2329) Shares?

New 90-day low: HK$0.83

Guorui Properties (HKG:2329) Has A Somewhat Strained Balance Sheet

New 90-day low: HK$0.84

New 90-day low: HK$0.94

First half earnings released

New 90-day low - HK$1.10

First half earnings released

Guorui Properties Limited to Report First Half, 2020 Results on Aug 31, 2020

Rendement voor aandeelhouders

Prijsvolatiliteit

Over het bedrijf

Glory Health Industry Limited Samenvatting